Cellgebra logo

Cellgebra

New strategies for target and biomarker discovery

1 employees · est. 2020 · Dublin, Ireland

VS
Immunai logo

Immunai

Mapping the Immune System with AI to Improve Health

174 employees · est. 2019 · New York, United States

Immunai is the older company (2020 vs 2019); Immunai is the larger of the two.

Side-by-Side Comparison

Cellgebra Immunai
Founded
2020 2019 older
Headquarters
Dublin, Ireland New York, United States
Employees
1 174 larger
Industry
Biotechnology Biotechnology, Pharmaceutical
Funding Stage
Not tracked yet Series B
Total Funding
Not tracked yet $300.50M
Funding Rounds
Not tracked yet 5
Services
Not tracked yet Target Discovery, Preclinical Evaluation, Clinical Trial Optimization, Data Generation, Data Augmentation, Compute and Validate Therapeutic Insights, Recommendation Engine
Target Customers
Not tracked yet biopharmaceutical companies, research institutions, pharma companies
Taxonomy
Cancer Clinical Trials, Biomarker Discovery, DNA Markers, RNA Markers, Drug Resistance Mechanisms, Target Identification, Cellular Networks, Cell Type Specific, Signalling Networks, Data-driven Computational Models, Cancer Drug Discovery Immune System Mapping, Single-cell Genomics, Biotech, Therapeutic Discoveries, Drug Development, Patient Outcomes, Biomarker Discovery, High-resolution Profiling, Immune Profiling, Cellular Response Analysis, Cancer Research, Genomic Technologies, High-dimensional Statistics, Single-cell Biology
Website
cellgebra.com immunai.com
Cellgebra logo

About Cellgebra

Cellgebra is a biotechnology startup based in Ireland that aims to revolutionize cancer clinical trials with their innovative approach to target and biomarker discovery. Their slogan "New strategies for target and biomarker discovery" encapsulates their commitment to improving the success rate of ca...

Immunai logo

About Immunai

Immunai, founded in 2019, is a United States-based startup that is revolutionizing the Biotechnology and Pharmaceutical industries with its innovative approach. The company's slogan, "Mapping the Immune System with AI to Improve Health," reflects its mission to map and decode the immune system using...

We will tell you when either one moves

BounceWatch watches Cellgebra and Immunai for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cellgebra and Immunai — by email.

Frequently Asked Questions

Cellgebra — New strategies for target and biomarker discovery . Immunai — Mapping the Immune System with AI to Improve Health. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cellgebra has raised undisclosed funding while Immunai has raised $300.50M.
Cellgebra and Immunai operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cellgebra with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cellgebra on 14 Sep 2024, and Immunai on 3 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy